SunBio,Inc.

SunBio, Inc. is a biotechnology company that develops, produces, and sells biosimilar and biopharmaceutical products and medical devices based on its pegylation technologies worldwide. Its biosimilar products include PEG-filgrastim, along with PEG-EPO and uricase, which are in the preclinical stage. The company also offers MucoPEG, a medical device for treating dry mouth syndrome, and SynoGEL, a viscosupplement for arthritic knee. Its preclinical biopharmaceutical candidates target brain stroke and chronic anemia, and it manufactures and sells PEG derivatives. SunBio was founded in 1997 and is headquartered in Gunpo-si, South Korea.